{
    "organizations": [],
    "uuid": "f8d1e410ae716767e4131dd876fae1219e13c4db",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-navidea-biopharmaceuticals-reports/brief-navidea-biopharmaceuticals-reports-q1-loss-per-share-0-04-idUSASC0A0RT",
    "ord_in_thread": 0,
    "title": "BRIEF-Navidea Biopharmaceuticals Reports Q1 Loss Per Share $0.04",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Navidea Biopharmaceuticals Inc:\n* NAVIDEA BIOPHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS\n* Q1 REVENUE $276,000 VERSUS $580,000 * Q1 LOSS PER SHARE $0.04 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T05:46:00.000+03:00",
    "crawled": "2018-05-09T12:39:43.063+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "navidea",
        "biopharmaceuticals",
        "inc",
        "navidea",
        "biopharmaceuticals",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "q1",
        "revenue",
        "versus",
        "q1",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}